This site is intended only for healthcare professionals residing in Singapore

Search

Menu

Close

Sign InLog Out Our medicinesTherapy areasExplore contentExplore contentEventsMaterialsVideosLet’s connectLet's ConnectContact usPfizer medical information

Menu

Close

DermatologyGastroenterologyRheumatology
GastroenterologyUlcerative Colitis Treatment with JAK Inhibitor 

Explore clinical evidence and resources to help healthcare professionals in the management and treatment of ulcerative colitis with Janus-kinase (JAK) inhibitors. 

 Learn more Crohn’s Disease and Ulcerative Colitis Treatment with Biological Therapy 

Explore clinical evidence and resources to help healthcare professionals in the management and treatment of Crohn’s disease and ulcerative colitis with biological therapy -  tumor necrosis factor (TNF) alfa blockers.

 Learn more
Abbreviations:JAK: Janus-kinase; TNF: tumor necrosis factor
PP-CIB-SGP-0056/28MAR2023
PfizerPro AccountPfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign inRegisterAccountSign Out

The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
 

Copyright © 2023 Pfizer Limited. All rights reserved.
You are now leaving the website
You are now leaving a Pfizer-operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.